Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00361101 · ClinicalTrials.gov registry record · Phase 1

A Study of AMD11070 in HIV-infected Patients Carrying X4-tropic Virus

A Phase 1 study of HIV Infections and X4 Tropic Virus, sponsored by Genzyme, a Sanofi Company.

Completed
Registry status
Phase 1
Development phase
10
Enrollment target
2
Study locations

NCT00361101 is a Phase 1 study of HIV Infections and X4 Tropic Virus that has completed, run by Genzyme, a Sanofi Company. The registered enrollment target is 10 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00361101, a Phase 1 study of HIV Infections and X4 Tropic Virus, has completed, sponsored by Genzyme, a Sanofi Company.

COMPLETED
Registry status
Phase 1
Development phase
10 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to determine the safety and activity of AMD11070 in HIV-infected patients carrying X4-tropic virus.

Conditions Studied

HIV Infections X4 Tropic Virus

Interventions

  • DRUG AMD11070

Study Locations (2)

Florida

  • - Orlando

Other

  • - London

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2005-10
Est. Completion 2010-04
Phase Phase 1

Sponsor

Genzyme, a Sanofi Company

196 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00361101

The ClinicalTrials.gov registry entry for NCT00361101 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (98% lower). The listed sponsor is Genzyme, a Sanofi Company, which has 196 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which AMD11070 is the first listed.

NCT00361101 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Other.

Frequently Asked Questions

What is clinical trial NCT00361101 about?

NCT00361101 is a clinical study titled "A Study of AMD11070 in HIV-infected Patients Carrying X4-tropic Virus". The purpose of this study is to determine the safety and activity of AMD11070 in HIV-infected patients carrying X4-tropic virus.

What is the current status of trial NCT00361101?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2005-10. Estimated completion is 2010-04.

What conditions does trial NCT00361101 study?

This clinical trial studies the following conditions: HIV Infections, X4 Tropic Virus.

What interventions are being tested in trial NCT00361101?

The interventions under investigation include: AMD11070 (DRUG).

Who is sponsoring clinical trial NCT00361101?

This trial is sponsored by Genzyme, a Sanofi Company, which has 196 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00361101 being conducted?

This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

X4 Tropic Virus

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.